Brazil health regulator Anvisa's technical staff recommend against importing Russia's Sputnik vaccine
Brazil's health regulator Anvisa's technical staff on Monday recommended against approving imports of the Russian-made Sputnik V COVID-19 vaccine requested by governors battling against a deadly second wave of the virus.
The technical staff's recommendations will be taken into account by Anvisa's board, which will announce its decision later on Monday. Anvisa had previously said there were "critical issues" surrounding the vaccine's effectiveness and safety that needed clarifying.
ALSO READ
-
IDB Approves $243m to Bring More Reliable Power to Brazil’s Santa Catarina
-
Brazil’s Tax Reform Gets IDB Loans for State Finances and Public Services
-
São Paulo’s $460M Ferry Overhaul Brings Electric Vessels and New Local Jobs
-
Brazil’s Paraíba Secures $50 Million to Build Stronger Water and Sanitation Services
-
AfDB and Brazil Deepen Mali Cooperation on Food, Jobs and Energy
Google News